Duclos, Philippe · Expert opinion on drug safety · 2003 · DOI
This review examined whether the hepatitis B vaccine is safe, particularly looking at claims that it might cause chronic fatigue syndrome, multiple sclerosis, diabetes, and other serious conditions. After reviewing scientific evidence from multiple independent health organizations including the WHO and US Institute of Medicine, researchers found no proof that the vaccine causes these conditions. The vaccine has a strong safety record, and the theoretical risks are far outweighed by its proven benefits in preventing liver disease and cancer.
This study is relevant to ME/CFS patients because chronic fatigue syndrome was explicitly examined as a purported vaccine-related adverse event and was found to lack supporting evidence. Understanding the safety profile of vaccines is important for ME/CFS patients when making informed health decisions about immunization, particularly given ongoing concerns about triggers or exacerbating factors in this population.
This review does not prove that ME/CFS cannot occur after vaccination in individual cases, nor does it establish mechanisms for why some patients report symptom onset following vaccination. It also does not address whether specific subpopulations with pre-existing conditions like ME/CFS might have different responses to hepatitis B vaccination. The review relies on existing institutional assessments rather than providing new primary data analysis.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Duclos, Philippe (2003). Safety of immunisation and adverse events following vaccination against hepatitis B.. Expert opinion on drug safety. https://doi.org/10.1517/14740338.2.3.225
BibTeX
@article{mecfsatlas-duclos-2003-safety-immunisation,
author = {Duclos, Philippe},
title = {Safety of immunisation and adverse events following vaccination against hepatitis B.},
journal = {Expert opinion on drug safety},
year = {2003},
doi = {10.1517/14740338.2.3.225},
note = {PubMed: 12904102},
url = {https://www.mecfsatlas.com/evidence/duclos-2003-safety-immunisation},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-26. https://www.mecfsatlas.com/evidence/duclos-2003-safety-immunisation
Contribute
Private, reviewed by a human. Not a public comment thread.